He has contributed to the development of management guidelines for HIV, TB and cryptococcal meningitis at a provincial and national level and in WHO Guideline Development Groups.
Recently, he was PI of the EDCTP-funded PredART trial that demonstrated that prednisone was effective and safe for the prevention of TB-IRIS in patients at high-risk starting ART, published in the New England Journal of Medicine in 2018. He has been the PI or local PI of several clinical trials and conducts observational cohort studies that address questions related to disease pathogenesis. His group also investigates drug-resistant tuberculosis and diagnostics for TB. Graeme Meintjes leads a research programme that focuses on the clinical conditions affecting patients with advanced HIV disease including disseminated HIV-associated tuberculosis, the tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) and cryptococcal meningitis.
Professor of Medicine, Second Chair and Deputy Head of the Department of Medicine DST/NRF SARChI Chair in Poverty-related Infections Adult Infectious Diseases Physician Member of the Institute of Infectious Disease and Molecular Medicine and Lead of the Clinical Platform of the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Faculty of Health Sciences, University of Cape Town (UCT). Selected publications | Contact details | Group members | Collaborations
Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa)